Drug Shortage Report for DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML

Last updated on 2023-02-10 History
Report ID 136036
Drug Identification Number 01934333
Brand name DEPO-MEDROL (WITH PRESERVATIVE) 40 MG/ML
Common or Proper name DEPO-MEDROL
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) METHYLPREDNISOLONE ACETATE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRASYNOVIAL
Packaging size 5 x 2mL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-08
Estimated end date
Actual end date 2023-02-09
Shortage status Resolved
Updated date 2023-02-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2023-02-10 French Compare
v16 2023-02-10 English Compare
v15 2023-02-09 French Compare
v14 2023-02-09 English Compare
v13 2022-01-12 French Compare
v12 2022-01-12 English Compare
v11 2021-09-09 English Compare
v10 2021-09-08 French Compare
v9 2021-09-08 English Compare
v8 2021-08-26 French Compare
v7 2021-08-26 English Compare
v6 2021-06-02 French Compare
v5 2021-06-02 English Compare
v4 2021-03-24 French Compare
v3 2021-03-24 English Compare
v2 2021-03-19 French Compare
v1 2021-03-19 English Compare

Showing 1 to 17 of 17